LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., (“Synageva”) (NASDAQ:GEVA) a clinical stage biopharmaceutical company developing therapeutic products for rare disorders announced today that it will be presenting at the upcoming 30th Annual J.P. Morgan Healthcare Conference, which is being held January 9-12, 2012, at the Westin St. Francis Hotel in San Francisco.
